Dengue encephalopathy in an adult due to dengue virus type 1 infection

© 2024. The Author(s)..

BACKGROUND: Dengue is an important public health problem, which caused by the dengue virus (DENV), a single-stranded RNA virus consisted of four serotypes. Central nervus system (CNS) impairment in dengue usually results from DENV-2 or DENV-3 infection, which lead to life-threatening outcomes. Furthermore, neurological complications due to DENV-1 was rare especially in adult patients.

CASE PRESENTATION: A 44-year-old man without comorbidities had lethargy after hyperpyrexia and a positive DENV NS1 antigen was detected for confirming the diagnosis of dengue on day 8 of onset. Then logagnosia, decreased muscle strength, delirium and irritability were occurred even radiographic examination were normal. He was treated with low-dose hormone, sedatives and gamma goblin with a short duration of 6 days. The cerebrospinal fluid (CSF) tests were persistent normal. However, presence of DENV-1 RNA was confirmed both in CSF and serum. Furthermore, the complete sequence of the DENV isolated from the patient's serum was performed (GenBank No.: MW261838). The cytokines as IL-6, IL-10 and sVCAM-1 were increased in critical phase of disease. Finally, the patient was discharged on day 24 of onset without any neurological sequelae.

CONCLUSION: Encephalopathy caused by a direct CNS invasion due to DENV-1 during viremia was described in an adult patient. Treatment with low-dose hormone and gamma goblin was helpful for admission.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

BMC infectious diseases - 24(2024), 1 vom: 15. März, Seite 319

Sprache:

Englisch

Beteiligte Personen:

Leng, Xingyu [VerfasserIn]
Yang, Huiqin [VerfasserIn]
Zhao, Lingzhai [VerfasserIn]
Feng, Jiamin [VerfasserIn]
Jin, Kanghong [VerfasserIn]
Liao, Lu [VerfasserIn]
Zhang, Fuchun [VerfasserIn]

Links:

Volltext

Themen:

Adult
Antibodies, Viral
Case Reports
Cytokines
DENV serotype 1
Dengue
Encephalopathy
Hormones
Journal Article

Anmerkungen:

Date Completed 18.03.2024

Date Revised 19.03.2024

published: Electronic

Citation Status MEDLINE

doi:

10.1186/s12879-024-09198-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369810392